| Product Name | Anti-Tn antigen Monoclonal Antibody, Culture Supernatant |
|---|---|
| Description | Mouse monoclonal antibody to human Tn Antigen Culture supernatant. Tn is a cryptantigen. It is defined as the core structure of O- glycans (aGalNAc-0-Ser/Thr) but different antibodies may require a contribution to the antigen structure from sialic acid substitution and/or adjacent polypeptide. The antigen is not expressed on normal haemopoietic cells but becomes exposed as a result of an acquired deficiency of b1,3 D-galactosyl transferase. Exposure of Tn antigen on haemopoietic cells is associated with polyagglutination2 and, in some cases thrombocytopenia and/or leucopenia. Detection of the antigen prior to the onset of leukemia has been reported3,4. The Tn antigen has also been described as a useful marker for some types of cancer cells. |
| Synonyms | Tn Antigen,Tn protein, Cryptantigen |
| Clonality | Monoclonal |
| Clone | BRIC111 |
| Immunogen | Tn Antigen. BRIC111 was made in response to Tn positive erythrocytes. It is a direct agglutinin of Tn erythrocytes but unreactive with normal erythrocytes including Group A1 erythrocytes. |
| Isotype | Mouse IgG2a kappa light chain |
| Reactivity | Human |
| Applications | IHC |
| Form | Culture Supernatant |
| Storage | 2-8C for immediate use, or at -2°C (aliquot) |
| References | 1. Cartron, JP., et al, (1978), Eur. J. Biochem. 92, 111-119. 2. Beck, ML., et al, (1977), Med. Lab. Sci. 34, 325-329. 3. Baldwin, ML., et al, (1979) Amer. J. Clin. Path. 72, 1024-1027. 4. Roxby, DJ, et al, (1987) Br. J. Haematol. 67, 153-156. 5. King, MJ., et al, (1991) Transfusion, 31, 142-149. 6. Chester MA et al (ed) (1990) Proceedings of the second international workshop and symposium on monoclonal antibodies against human red blood cells and related antigens, Lund 1990 7. Brooks S.A et al (1995) Expression of alph-GalNAc glycoproteins by breast cancers. Bristish J. of Cancer 71, 1033-1038 |
| Supplier | ARP |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
